Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 12 Also abroad 224

12 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
A Study of AZD0120 in Autoimmune Diseases
Where
Edinburgh, London
Életkor
18 év to 75 év
People
27 worldwide
Run by
AstraZeneca
See details and how to joinNCT07295847
3. fázisTaking people
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Where
Cambridge, Leeds, London, Newcastle upon Tyne, Sheffield
Életkor
5 év to 80 év
People
1072 worldwide
Run by
AstraZeneca
See details and how to joinNCT07691970
1/2. fázisTaking people
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Where
Birmingham, Leeds, London, Manchester, Newcastle, Oxford
Életkor
18 év and over
People
16 worldwide
Run by
Quell Therapeutics Limited
See details and how to joinNCT07473154
3. fázisTaking people
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Where
Bristol, Leeds, London, Salford
Életkor
18 év and over
People
448 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00
2. fázisTaking people
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Where
Coventry, Liverpool, London, Westcliff-on-Sea
Életkor
18 év and over
People
85 worldwide
Run by
Mediar Therapeutics
See details and how to joinNCT07287670
3. fázisNot yet taking people in Egyesült Királyság
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Where
Leeds, London, Sheffield
Életkor
16 év and over
People
92 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07335562 · EU 2025-524337-11-00
3. fázisTaking people
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Where
Leeds, London
Életkor
18 év and over
People
514 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06716606
2/3. fázisTaking people
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Where
Birmingham, Leeds, London, Portsmouth, Wakefield
Életkor
18 év and over
People
300 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01
No phaseTaking people
DERMATOMICS: Identifying Regulators of Skin Homeostasis
Where
Leeds, London
Életkor
18 év and over
People
500
Run by
Relation Therapeutics
See details and how to joinNCT06894654
1. fázisTaking people
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Where
Cambridge, London, Manchester
Életkor
12 év to 70 év
People
244 worldwide
Run by
Fate Therapeutics
See details and how to joinNCT06308978
No phaseTaking people
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
Where
Liverpool, Newcastle upon Tyne
Életkor
Up to 18 év
People
20 worldwide
Run by
Meyer Children's Hospital IRCCS
See details and how to joinNCT07348263
No phaseCsak meghívásos
Chest CT Biomarkers as Prognostic Predictors in SSc-ILD
Where
Leeds, London
Életkor
18 év to 99 év
People
1000 worldwide
Run by
Royal Brompton & Harefield NHS Foundation Trust
See details and how to joinNCT06472362